Samsung Bioepis Celebrates ISO 37301 Certification
Samsung Bioepis has proudly received the ISO 37301 certification from the International Organization for Standardization (ISO), marking a significant milestone in its commitment to compliance and ethical business practices. The certification ceremony, held at the Samsung Bioepis headquarters, was attended by key figures including CEO Kim Kyung-ah and representatives from the British Standards Institution (BSI).

Understanding ISO 37301
ISO 37301 is an international standard that evaluates a company's internal processes for managing compliance risks and adhering to legal and ethical standards. Samsung Bioepis' achievement underscores its dedication to maintaining a robust compliance management system and fostering a sustainable ethical culture.
A Commitment to Global Standards
CEO Kim Kyung-ah emphasized the importance of building a compliance system based on international standards to strengthen trust with global partners and customers. This certification is a testament to Samsung Bioepis' ongoing efforts to lead with integrity and compliance in the biopharmaceutical industry.
By Business Korea Kim Hyun-min ([email protected])
Comments